Omnispirant

Startup

Omnispirant

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem. Sign in

Omnispirant

Address

Galway, Ireland

Contact

gmccauley@omnispirant.com

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem.

Matchmaking

Connect with Omnispirant

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

Omnispirant last news

04/05/2023

OmniSpirant Limited Appoints Andy Fisher to its Board of Directors

Galway, Ireland 4th May 2023 OmniSpirant is excited to announce the appointment of Andy Fisher to its board of directors. For nearly 20 years, Andy held leadership positions at United Therapeutics Corporation, a global biotechnology company focused on chronic and life-threatening conditions in areas of unmet medical need. Most recently, he was Chief Strategy Officer [...] The post OmniSpirant Limited Appoints Andy Fisher to its Board of Directors appeared first on Omnispirant .

20/01/2023

Emily's Entourage Grants $220k to Queen's University Belfast to advance OmniSpirant's Gene Therapy for Cystic Fibrosis

PRESS RELEASE We are excited to progress the development of OS001 for CF in collaboration with Prof Lorraine Martin and Dr Lisa Douglas in Queen's University Belfast. Funding support from Emily's Entourage in the USA and The CF Trust in the UK is matched by their scientific expertise which will help to shape further exciting [...] The post Emily's Entourage Grants $220k to Queen's University Belfast to advance OmniSpirant's Gene Therapy for Cystic Fibrosis appeared first on Omnispirant .

14/12/2022

OmniSpirant Limited Announces the Launch of INSPIRE; an EU Project funded under the Horizon Europe research and innovation programme to develop a ground-breaking inhaled gene therapy for the treatment of lung cancer.

PRESS RELEASE OmniSpirant Limited are delighted and honoured to announce the launch of INSPIRE, a €12.8 million lung cancer project funded by Horizon Europe. In one of the largest ever grants for preclinical research in lung cancer, OmniSpirant in collaboration with our European partners spanning across biotechnology, medical devices, cancer research, academia and patient advocacy, [...] The post OmniSpirant Limited Announces the Launch of INSPIRE; an EU Project funded under the Horizon Europe research and innovation programme to develop a ground-breaking inhaled gene therapy for the treatment of lung cancer. appeared first on Omnispirant .